Loading…

A novel diclofenac-hydrogel conjugate system for intraarticular sustained release: Development of 2-pyridylamino-substituted 1-phenylethanol (PAPE) and its derivatives as tunable traceless linkers

[Display omitted] A local sustained-release drug delivery system, or depot, for intra-articular injection offers the opportunity to release a therapeutic agent directly to the joint with limited need for reinjection. A successful system would provide more consistent efficacy and minimize systemic si...

Full description

Saved in:
Bibliographic Details
Published in:International journal of pharmaceutics 2020-07, Vol.585, p.119519-119519, Article 119519
Main Authors: Kawanami, Toshio, LaBonte, Laura R., Amin, Jakal, Thibodeaux, Stefan J., Lee, Cameron C., Argintaru, O. Andreea, Adams, Christopher M.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c365t-77bd893f5885ed11c5ab39723f1425dd32739d3c194e13150e4d01baf9001dd23
cites cdi_FETCH-LOGICAL-c365t-77bd893f5885ed11c5ab39723f1425dd32739d3c194e13150e4d01baf9001dd23
container_end_page 119519
container_issue
container_start_page 119519
container_title International journal of pharmaceutics
container_volume 585
creator Kawanami, Toshio
LaBonte, Laura R.
Amin, Jakal
Thibodeaux, Stefan J.
Lee, Cameron C.
Argintaru, O. Andreea
Adams, Christopher M.
description [Display omitted] A local sustained-release drug delivery system, or depot, for intra-articular injection offers the opportunity to release a therapeutic agent directly to the joint with limited need for reinjection. A successful system would provide more consistent efficacy and minimize systemic side effects. In this paper, we explore the potential use of diclofenac, a non-steroidal anti-inflammatory drug, for use in a polymer-conjugate depot system. During the course of our exploration it was determined that “conventional ester” conjugates of diclofenac were not appropriate as upon incubation in buffer (pH 7.4) or in bovine synovial fluid, a considerable amount of undesired diclofenac-lactam was released. Thus we developed a novel linker system for diclofenac in order to minimize the production of the lactam. This new linker enables a diclofenac conjugate system with tunable release rates and minimizes the production of undesired lactam side-products.
doi_str_mv 10.1016/j.ijpharm.2020.119519
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2414012301</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0378517320305032</els_id><sourcerecordid>2414012301</sourcerecordid><originalsourceid>FETCH-LOGICAL-c365t-77bd893f5885ed11c5ab39723f1425dd32739d3c194e13150e4d01baf9001dd23</originalsourceid><addsrcrecordid>eNqFkU9v1DAQxSMEokvhI4B8LIcs_hNvNlzQqrSAVIke4Gw59qTrxbGDx1kp348PhqvdcuU00tN782b0q6q3jK4ZZZsPh7U7THudxjWnvGisk6x7Vq3YthW1aNrN82pFRbutJWvFRfUK8UAp3XAmXlYXgksh6aZbVX92JMQjeGKd8XGAoE29X2yKD0UzMRzmB52B4IIZRjLERFzISeuUnZm9TgRnzNoFsCSBB43wkXyGsjBOI4RM4kB4PS3J2cXr0YVY49xjdnnOJcLqaQ9h8ZD3OkRPru539zfviQ6WuIzEQnJHnd0RkGgkeQ6690BKvyldiMS78AsSvq5eDNojvDnPy-rn7c2P66_13fcv3653d7URG5nrtu3tthOD3G4lWMaM1L3oWi4G1nBpreCt6KwwrGuACSYpNJayXg8dpcxaLi6rq9PeKcXfM2BWo8NyitcB4oyKN6yhjAvKilWerCZFxASDmpIbdVoUo-oRoDqoM0D1CFCdAJbcu3PF3I9g_6WeiBXDp5MByqNHB0mhcRAMWJfAZGWj-0_FX_9Vs7Y</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2414012301</pqid></control><display><type>article</type><title>A novel diclofenac-hydrogel conjugate system for intraarticular sustained release: Development of 2-pyridylamino-substituted 1-phenylethanol (PAPE) and its derivatives as tunable traceless linkers</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Kawanami, Toshio ; LaBonte, Laura R. ; Amin, Jakal ; Thibodeaux, Stefan J. ; Lee, Cameron C. ; Argintaru, O. Andreea ; Adams, Christopher M.</creator><creatorcontrib>Kawanami, Toshio ; LaBonte, Laura R. ; Amin, Jakal ; Thibodeaux, Stefan J. ; Lee, Cameron C. ; Argintaru, O. Andreea ; Adams, Christopher M.</creatorcontrib><description>[Display omitted] A local sustained-release drug delivery system, or depot, for intra-articular injection offers the opportunity to release a therapeutic agent directly to the joint with limited need for reinjection. A successful system would provide more consistent efficacy and minimize systemic side effects. In this paper, we explore the potential use of diclofenac, a non-steroidal anti-inflammatory drug, for use in a polymer-conjugate depot system. During the course of our exploration it was determined that “conventional ester” conjugates of diclofenac were not appropriate as upon incubation in buffer (pH 7.4) or in bovine synovial fluid, a considerable amount of undesired diclofenac-lactam was released. Thus we developed a novel linker system for diclofenac in order to minimize the production of the lactam. This new linker enables a diclofenac conjugate system with tunable release rates and minimizes the production of undesired lactam side-products.</description><identifier>ISSN: 0378-5173</identifier><identifier>EISSN: 1873-3476</identifier><identifier>DOI: 10.1016/j.ijpharm.2020.119519</identifier><identifier>PMID: 32535069</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>2-Pyridylamino substituted 1-phenylethanol (PAPE) ; Animals ; Anti-Inflammatory Agents, Non-Steroidal - administration &amp; dosage ; Benzyl Alcohols - chemistry ; Cattle ; Chemistry, Pharmaceutical - methods ; Delayed-Action Preparations ; Diclofenac ; Diclofenac - administration &amp; dosage ; Drug delivery system ; Drug Delivery Systems - methods ; Humans ; Hydrogel ; Hydrogels - chemistry ; Hydrogen-Ion Concentration ; Injections, Intra-Articular ; Osteoarthritis ; Polymeric prodrug ; Prodrugs ; Sustained release ; Synovial Fluid</subject><ispartof>International journal of pharmaceutics, 2020-07, Vol.585, p.119519-119519, Article 119519</ispartof><rights>2020 Elsevier B.V.</rights><rights>Copyright © 2020 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c365t-77bd893f5885ed11c5ab39723f1425dd32739d3c194e13150e4d01baf9001dd23</citedby><cites>FETCH-LOGICAL-c365t-77bd893f5885ed11c5ab39723f1425dd32739d3c194e13150e4d01baf9001dd23</cites><orcidid>0000-0001-7721-366X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32535069$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kawanami, Toshio</creatorcontrib><creatorcontrib>LaBonte, Laura R.</creatorcontrib><creatorcontrib>Amin, Jakal</creatorcontrib><creatorcontrib>Thibodeaux, Stefan J.</creatorcontrib><creatorcontrib>Lee, Cameron C.</creatorcontrib><creatorcontrib>Argintaru, O. Andreea</creatorcontrib><creatorcontrib>Adams, Christopher M.</creatorcontrib><title>A novel diclofenac-hydrogel conjugate system for intraarticular sustained release: Development of 2-pyridylamino-substituted 1-phenylethanol (PAPE) and its derivatives as tunable traceless linkers</title><title>International journal of pharmaceutics</title><addtitle>Int J Pharm</addtitle><description>[Display omitted] A local sustained-release drug delivery system, or depot, for intra-articular injection offers the opportunity to release a therapeutic agent directly to the joint with limited need for reinjection. A successful system would provide more consistent efficacy and minimize systemic side effects. In this paper, we explore the potential use of diclofenac, a non-steroidal anti-inflammatory drug, for use in a polymer-conjugate depot system. During the course of our exploration it was determined that “conventional ester” conjugates of diclofenac were not appropriate as upon incubation in buffer (pH 7.4) or in bovine synovial fluid, a considerable amount of undesired diclofenac-lactam was released. Thus we developed a novel linker system for diclofenac in order to minimize the production of the lactam. This new linker enables a diclofenac conjugate system with tunable release rates and minimizes the production of undesired lactam side-products.</description><subject>2-Pyridylamino substituted 1-phenylethanol (PAPE)</subject><subject>Animals</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - administration &amp; dosage</subject><subject>Benzyl Alcohols - chemistry</subject><subject>Cattle</subject><subject>Chemistry, Pharmaceutical - methods</subject><subject>Delayed-Action Preparations</subject><subject>Diclofenac</subject><subject>Diclofenac - administration &amp; dosage</subject><subject>Drug delivery system</subject><subject>Drug Delivery Systems - methods</subject><subject>Humans</subject><subject>Hydrogel</subject><subject>Hydrogels - chemistry</subject><subject>Hydrogen-Ion Concentration</subject><subject>Injections, Intra-Articular</subject><subject>Osteoarthritis</subject><subject>Polymeric prodrug</subject><subject>Prodrugs</subject><subject>Sustained release</subject><subject>Synovial Fluid</subject><issn>0378-5173</issn><issn>1873-3476</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNqFkU9v1DAQxSMEokvhI4B8LIcs_hNvNlzQqrSAVIke4Gw59qTrxbGDx1kp348PhqvdcuU00tN782b0q6q3jK4ZZZsPh7U7THudxjWnvGisk6x7Vq3YthW1aNrN82pFRbutJWvFRfUK8UAp3XAmXlYXgksh6aZbVX92JMQjeGKd8XGAoE29X2yKD0UzMRzmB52B4IIZRjLERFzISeuUnZm9TgRnzNoFsCSBB43wkXyGsjBOI4RM4kB4PS3J2cXr0YVY49xjdnnOJcLqaQ9h8ZD3OkRPru539zfviQ6WuIzEQnJHnd0RkGgkeQ6690BKvyldiMS78AsSvq5eDNojvDnPy-rn7c2P66_13fcv3653d7URG5nrtu3tthOD3G4lWMaM1L3oWi4G1nBpreCt6KwwrGuACSYpNJayXg8dpcxaLi6rq9PeKcXfM2BWo8NyitcB4oyKN6yhjAvKilWerCZFxASDmpIbdVoUo-oRoDqoM0D1CFCdAJbcu3PF3I9g_6WeiBXDp5MByqNHB0mhcRAMWJfAZGWj-0_FX_9Vs7Y</recordid><startdate>20200730</startdate><enddate>20200730</enddate><creator>Kawanami, Toshio</creator><creator>LaBonte, Laura R.</creator><creator>Amin, Jakal</creator><creator>Thibodeaux, Stefan J.</creator><creator>Lee, Cameron C.</creator><creator>Argintaru, O. Andreea</creator><creator>Adams, Christopher M.</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-7721-366X</orcidid></search><sort><creationdate>20200730</creationdate><title>A novel diclofenac-hydrogel conjugate system for intraarticular sustained release: Development of 2-pyridylamino-substituted 1-phenylethanol (PAPE) and its derivatives as tunable traceless linkers</title><author>Kawanami, Toshio ; LaBonte, Laura R. ; Amin, Jakal ; Thibodeaux, Stefan J. ; Lee, Cameron C. ; Argintaru, O. Andreea ; Adams, Christopher M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c365t-77bd893f5885ed11c5ab39723f1425dd32739d3c194e13150e4d01baf9001dd23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>2-Pyridylamino substituted 1-phenylethanol (PAPE)</topic><topic>Animals</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - administration &amp; dosage</topic><topic>Benzyl Alcohols - chemistry</topic><topic>Cattle</topic><topic>Chemistry, Pharmaceutical - methods</topic><topic>Delayed-Action Preparations</topic><topic>Diclofenac</topic><topic>Diclofenac - administration &amp; dosage</topic><topic>Drug delivery system</topic><topic>Drug Delivery Systems - methods</topic><topic>Humans</topic><topic>Hydrogel</topic><topic>Hydrogels - chemistry</topic><topic>Hydrogen-Ion Concentration</topic><topic>Injections, Intra-Articular</topic><topic>Osteoarthritis</topic><topic>Polymeric prodrug</topic><topic>Prodrugs</topic><topic>Sustained release</topic><topic>Synovial Fluid</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kawanami, Toshio</creatorcontrib><creatorcontrib>LaBonte, Laura R.</creatorcontrib><creatorcontrib>Amin, Jakal</creatorcontrib><creatorcontrib>Thibodeaux, Stefan J.</creatorcontrib><creatorcontrib>Lee, Cameron C.</creatorcontrib><creatorcontrib>Argintaru, O. Andreea</creatorcontrib><creatorcontrib>Adams, Christopher M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of pharmaceutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kawanami, Toshio</au><au>LaBonte, Laura R.</au><au>Amin, Jakal</au><au>Thibodeaux, Stefan J.</au><au>Lee, Cameron C.</au><au>Argintaru, O. Andreea</au><au>Adams, Christopher M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A novel diclofenac-hydrogel conjugate system for intraarticular sustained release: Development of 2-pyridylamino-substituted 1-phenylethanol (PAPE) and its derivatives as tunable traceless linkers</atitle><jtitle>International journal of pharmaceutics</jtitle><addtitle>Int J Pharm</addtitle><date>2020-07-30</date><risdate>2020</risdate><volume>585</volume><spage>119519</spage><epage>119519</epage><pages>119519-119519</pages><artnum>119519</artnum><issn>0378-5173</issn><eissn>1873-3476</eissn><abstract>[Display omitted] A local sustained-release drug delivery system, or depot, for intra-articular injection offers the opportunity to release a therapeutic agent directly to the joint with limited need for reinjection. A successful system would provide more consistent efficacy and minimize systemic side effects. In this paper, we explore the potential use of diclofenac, a non-steroidal anti-inflammatory drug, for use in a polymer-conjugate depot system. During the course of our exploration it was determined that “conventional ester” conjugates of diclofenac were not appropriate as upon incubation in buffer (pH 7.4) or in bovine synovial fluid, a considerable amount of undesired diclofenac-lactam was released. Thus we developed a novel linker system for diclofenac in order to minimize the production of the lactam. This new linker enables a diclofenac conjugate system with tunable release rates and minimizes the production of undesired lactam side-products.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>32535069</pmid><doi>10.1016/j.ijpharm.2020.119519</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0001-7721-366X</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0378-5173
ispartof International journal of pharmaceutics, 2020-07, Vol.585, p.119519-119519, Article 119519
issn 0378-5173
1873-3476
language eng
recordid cdi_proquest_miscellaneous_2414012301
source ScienceDirect Freedom Collection 2022-2024
subjects 2-Pyridylamino substituted 1-phenylethanol (PAPE)
Animals
Anti-Inflammatory Agents, Non-Steroidal - administration & dosage
Benzyl Alcohols - chemistry
Cattle
Chemistry, Pharmaceutical - methods
Delayed-Action Preparations
Diclofenac
Diclofenac - administration & dosage
Drug delivery system
Drug Delivery Systems - methods
Humans
Hydrogel
Hydrogels - chemistry
Hydrogen-Ion Concentration
Injections, Intra-Articular
Osteoarthritis
Polymeric prodrug
Prodrugs
Sustained release
Synovial Fluid
title A novel diclofenac-hydrogel conjugate system for intraarticular sustained release: Development of 2-pyridylamino-substituted 1-phenylethanol (PAPE) and its derivatives as tunable traceless linkers
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T07%3A31%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20novel%20diclofenac-hydrogel%20conjugate%20system%20for%20intraarticular%20sustained%20release:%20Development%20of%202-pyridylamino-substituted%201-phenylethanol%20(PAPE)%20and%20its%20derivatives%20as%20tunable%20traceless%20linkers&rft.jtitle=International%20journal%20of%20pharmaceutics&rft.au=Kawanami,%20Toshio&rft.date=2020-07-30&rft.volume=585&rft.spage=119519&rft.epage=119519&rft.pages=119519-119519&rft.artnum=119519&rft.issn=0378-5173&rft.eissn=1873-3476&rft_id=info:doi/10.1016/j.ijpharm.2020.119519&rft_dat=%3Cproquest_cross%3E2414012301%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c365t-77bd893f5885ed11c5ab39723f1425dd32739d3c194e13150e4d01baf9001dd23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2414012301&rft_id=info:pmid/32535069&rfr_iscdi=true